Results 161 to 170 of about 4,938,261 (300)

Can somatic GATA2 mutation mimic germ line GATA2 mutation? [PDF]

, 2018
Somatic GATA2 mutation is associated with immunodeficiency and pulmonary alveolar proteinosis in a patient with myeloproliferative ...
Collin, M, Dickinson, R, Lipman, M, Lowe, D, Marafioti, T, Mitchell, C, Pocock, R, Sekhar, M   +7 more
core  

Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome

Clinics, 2013
OBJECTIVES: To evaluate whether risk scores used to classify patients with primary myelofibrosis and JAK-2 V617F mutation status can predict clinical outcome.
Bruno Deltreggia Benites, Carolina Silva Costa Lima, Irene Lorand-Metze, Marcia Torresan Delamain, Gislaine Borba Oliveira, Daiane de Almeida, Carmino Antonio de Souza, Jose Vassallo, Katia Borgia Barbosa Pagnano   +8 more
doaj  

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia-telangiectasia. [PDF]

, 2018
Ataxia-telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential ...
Bateni, Cyrus P, Canter, Robert J, Darrow, Morgan A, Evans, Christopher P, Judge, Sean James, Plescia, Trevor A   +5 more
core  

Thrombosis at unusual sites in reproductive age group-a case series [PDF]

, 2016
Thrombosis is one of the causes of morbidity and mortality in women of reproductive age group. Thrombosis at unusual sites may pose diagnostic and management dilemma for health care personnel.
Khalid, Bahariah, Md Noor, Sabariah, Mohd Tohit, Eusni Rahayu, Seman, Zainina   +3 more
core   +1 more source

Reticulosarcomatosis in primary myelofibrosis [PDF]

Cancer, 1968
openaire   +2 more sources

Clinical features and treatment of newly diagnosed multiple myeloma with secondary myelofibrosis: a retrospective study

Therapeutic Advances in Hematology
Background: Secondary myelofibrosis (SMF) is characterized by the excessive deposition of fibrous tissue on top of the primary disease, often causing clinical manifestations to be overshadowed by the primary disease.
Han Xu, Yujie Xu, Mengying Wang, Chunxia Mao, Junxia Huang, Tianlan Li, Yan Gao, Shanshan Liu, Jingjing Zhou, Yi Zhang, Xianqi Feng   +10 more
doaj   +1 more source

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience [PDF]

, 2012
Ayalew Tefferi, Terra L. Lasho, Thitina Jimma, Christy M. Finke, Naseema Gangat, Rakhee Vaidya, Kebede H. Begna, Aref Al‐Kali, Rhett P. Ketterling, Curtis A. Hanson, Animesh Pardanani   +10 more
openalex   +1 more source

MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? [PDF]

, 2019
Accurso, V., Cordova, A., Di Piazza, F., Di Stefano, A. B., Lo Re, J., Mancuso, S., Russo, A., Santoro, M., Siragusa, S.   +8 more
core   +1 more source

Supplemental Table S1 from Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary Myelofibrosis

, 2023
Christophe Martinaud, Christophe Desterke, Johanna Konopacki, Lisa Pieri, Fréderic Torossian, Rachel Golub, Sandrine Schmutz, Adrienne Anginot, Bernadette Guerton, Nathalie Rochet, Patricia Albanese, Emilie Hénault, Olivier Pierre-Louis, Jean-Baptiste Souraud, Thierry de Revel, Brigitte Dupriez, Jean‐Christophe Ianotto, Marie‐Françoise Bourgeade, Alessandro M. Vannucchi, Jean‐Jacques Lataillade, Marie‐Caroline Le Bousse‐Kerdilès   +20 more
openalex   +2 more sources

Construction of gene/protein interaction networks for primary myelofibrosis and KEGG pathway-enrichment analysis of molecular compounds

, 2015
Changgang Sun, Xiaoyi Cao, Chengbin Zhou, L.J. Liu, Fubin Feng, Rong-rong Liu, Jing Zhuang, Y.J. Li   +7 more
openalex   +1 more source